{"title":"On the 40th anniversary of the discovery of Helicobacter pylori","authors":"V. Reshetnyak, A. I. Burmistrov","doi":"10.52888/0514-2515-2022-353-2-121-134","DOIUrl":null,"url":null,"abstract":" The review is dedicated to the analysis of the accumulated data on the study of Helicobacter pylori (H. pylori) since the detailed description of this bacterium as the main etiological factor of gastrointestinal diseases. The work shows the dual role of H. pylori both as a bacterial pathogen for humans and as a potential representative of the normal microbiome of the stomach. In most scientific publications, the attention of researchers is focused entirely on the consideration of the pathogenic properties of H. pylori in the development of chronic gastritis, peptic ulcer disease (PUD) and gastric cancer (GC), and also considers the development of effective methods of eradication therapy. Along with this, in recent years, more and more often there are works that indicate a potentially positive effect of this bacterium on the human body and the occurrence of a number of negative consequences after eradication therapy. In this connection, the question of the probable affiliation of H. pylori to the composition of the human microbiome is discussed. Data on the high prevalence of the microorganism in the population and its asymptomatic coexistence with humans indicate the persistence of the bacterium in the body, most likely as a representative of the microbiome. The accumulated data on the effect of H. pylori on human health demonstrate a clear ambiguity of the problem. In this regard, it is important to answer the question whether it is necessary to create programs for mass eradication of H. pylori, or whether it is necessary to approach the implementation of eradication therapy in a more personalized way.","PeriodicalId":345517,"journal":{"name":"Health care of Tajikistan","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health care of Tajikistan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52888/0514-2515-2022-353-2-121-134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The review is dedicated to the analysis of the accumulated data on the study of Helicobacter pylori (H. pylori) since the detailed description of this bacterium as the main etiological factor of gastrointestinal diseases. The work shows the dual role of H. pylori both as a bacterial pathogen for humans and as a potential representative of the normal microbiome of the stomach. In most scientific publications, the attention of researchers is focused entirely on the consideration of the pathogenic properties of H. pylori in the development of chronic gastritis, peptic ulcer disease (PUD) and gastric cancer (GC), and also considers the development of effective methods of eradication therapy. Along with this, in recent years, more and more often there are works that indicate a potentially positive effect of this bacterium on the human body and the occurrence of a number of negative consequences after eradication therapy. In this connection, the question of the probable affiliation of H. pylori to the composition of the human microbiome is discussed. Data on the high prevalence of the microorganism in the population and its asymptomatic coexistence with humans indicate the persistence of the bacterium in the body, most likely as a representative of the microbiome. The accumulated data on the effect of H. pylori on human health demonstrate a clear ambiguity of the problem. In this regard, it is important to answer the question whether it is necessary to create programs for mass eradication of H. pylori, or whether it is necessary to approach the implementation of eradication therapy in a more personalized way.
本综述旨在对幽门螺杆菌(Helicobacter pylori, H. pylori)作为胃肠道疾病主要病因的详细描述以来积累的研究资料进行分析。这项工作显示了幽门螺旋杆菌的双重作用,既是人类的细菌病原体,也是胃中正常微生物群的潜在代表。在大多数科学出版物中,研究人员的注意力完全集中在考虑幽门螺杆菌在慢性胃炎、消化性溃疡病(PUD)和胃癌(GC)发展中的致病特性,并考虑开发有效的根除治疗方法。与此同时,近年来,越来越多的研究表明,这种细菌对人体有潜在的积极作用,在根除治疗后也会出现一些负面后果。在这方面,讨论了幽门螺杆菌可能与人类微生物组组成有关的问题。有关该微生物在人群中的高流行率及其与人类无症状共存的数据表明,该细菌在体内持续存在,很可能是微生物组的代表。关于幽门螺杆菌对人类健康影响的累积数据表明,这一问题明显模棱两可。在这方面,重要的是要回答是否有必要建立大规模根除幽门螺杆菌的计划,或者是否有必要以更个性化的方式实施根除治疗。